Two step capture and purification of IgG2 using multicolumn countercurrent solvent gradient purification (MCSGP) |
| |
| Authors: | T. Müller‐Späth L. Aumann G. Ströhlein H. Kornmann P. Valax L. Delegrange E. Charbaut G. Baer A. Lamproye M. Jöhnck M. Schulte M. Morbidelli |
| |
| Affiliation: | 1. Institute for Chemical and Bioengineering, ETH Zurich, CH‐8093 Zurich, Switzerland;2. telephone: +41‐44‐6323034/+41‐44‐6323033;3. fax: +41‐44‐6321082;4. ChromaCon AG, Technoparkstr. 1, Zurich, Switzerland;5. Merck Serono S.A., Zone Industrielle l'Ouriettaz, Aubonne, Switzerland;6. Merck Serono S.A., Zone Industrielle B, Fenil‐sur‐Corsier, Switzerland;7. Merck KGaA, Performance & Life Science Chemicals Research & Development—Life Science, Darmstadt, Germany |
| |
| Abstract: | A two‐step chromatography process for monoclonal antibody (mAb) purification from clarified cell culture supernatant (cCCS) was developed using cation exchange Multicolumn Countercurrent Solvent Gradient Purification (MCSGP) as a capture step. After an initial characterization of the cell culture supernatant the capture step was designed from a batch gradient elution chromatogram. A variety of chromatographic materials was screened for polishing of the MCSGP‐captured material in batch mode. Using multi‐modal anion exchange in bind‐elute mode, mAb was produced consistently within the purity specification. The benchmark was a state‐of‐the‐art 3‐step chromatographic process based on protein A, anion and cation exchange stationary phases. The performance of the developed 2‐step process was compared to this process in terms of purity, yield, productivity and buffer consumption. Finally, the potential of the MCSGP process was investigated by comparing its performance to that of a classical batch process that used the same stationary phase. Biotechnol. Bioeng. 2010;107: 974–984. © 2010 Wiley Periodicals, Inc. |
| |
| Keywords: | MCSGP monoclonal antibody continuous chromatography |
|
|
